Publication | Closed Access

Effects on survival of the adverse event of atezolizumab plus bevacizumab for hepatocellular carcinoma: a multicenter study by the Japan Red Cross Liver Study Group

HepatologyAdverse EventMedicineImmunologyPathologyPharmacotherapyLiver CancerMulticenter StudyOncologyRadiation OncologyHepatocellular CarcinomaCancer Research